Delivery Order SPE2DB20D3304-SPE2DB23FW7J3

Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $177
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, has a potential value of one hundred thirty-seven dollars. The order is for the delivery of TESTOSTERONE CYP 200 MG/MLML to a location in Conshohocken, Pennsylvania. It was awarded on October 10, 2023 under a firm fixed price contract vehicle and is to be completed by October 11, 2023. No set-aside designation was applied to this order. The Defense Logistics Agency manages the global supply chain for the...
This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, has a potential value of one hundred thirty-three dollars. The order is for the delivery of TESTOSTERONE CYP 200 MG/MLML, with an anticipated completion date of October 23, 2023. Issued under a firm fixed price contract vehicle and without a set-aside designation, the place of performance will be Conshohocken, Pennsylvania. As a leading pharmaceutical supplier, Amerisourcebergen will leverage its...
This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, has a potential value of two hundred eighteen dollars. The order is for the delivery of TESTOSTERONE CYP 200 MG/MLML to a location in Conshohocken, Pennsylvania. The completion date is October 23, 2023. No set-aside designation was used for this firm fixed price order. As the Defense Logistics Agency is responsible for worldwide logistics support for the U.S. Department of Defense, this order is...
This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, has a potential value of thirty-six dollars to provide TESTOSTERONE CYP 200 MG/MLML. The order was awarded on September 19, 2023 under Amerisourcebergen's Corporate Office contract vehicle and requires completion by September 20, 2023. To be performed in Conshohocken, Pennsylvania, this firm fixed price order utilizes no set-aside designation and furthers the Defense Logistics Agency's mission to provide...
The Defense Logistics Agency awarded a $1,149.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561566547 TESTOSTERONE CYP 200 MG/MLML. The prime contractor, Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the products from its location in Conshohocken, Pennsylvania to fulfill the agency's requirements. The period of performance is July 21-24, 2023. As a major provider of medical supplies and...
The Defense Logistics Agency awarded a $388.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of TESTOSTERONE CYP 200 MG/MLML. The single day order, issued on August 8, 2023, will be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite delivery/indefinite quantity contract...
This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, has a potential value of one hundred nine dollars. The firm fixed price order is for the delivery of TESTOSTERONE CYP 200 MG/MLML, with an anticipated completion date of October 23, 2023. As the award was made through an existing vehicle without a set-aside designation, it is likely associated with a DLA pharmaceuticals contract to supply products to support military treatment facilities....
The Defense Logistics Agency awarded a $136,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TESTOSTERONE CYP 200 MG/MLML under contract number 4561867452. The order is to be performed in Conshohocken, Pennsylvania from August 18-21, 2023. No additional details were provided regarding the original solicitation or any overarching contracts, however based on the product description and involvement of the Defense Logistics Agency, the delivery order is likely in support...
The Defense Logistics Agency awarded a $456 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TESTOSTERONE CYP 200 MG/MLML. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania under a one-day period of performance from July 12 to July 13, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely procures pharmaceuticals and medical supplies to...
The Defense Logistics Agency awarded a $228,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TESTOSTERONE CYP 200 MG/MLML. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Performance will take place in Conshohocken, Pennsylvania over a one-day period in early September 2023. No subcontractors or set aside designations were identified. The...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB23FW7J3
    Delivery Order

This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, has a potential value of one hundred seventy-seven US dollars. The order is for TESTOSTERONE CYP 200 MG/MLML under a firm fixed price contract with no set-aside designation. Performance will occur at the awardee's Conshohocken, Pennsylvania location by the September 19, 2023 completion date. As this delivery order was issued by the Defense Logistics Agency to fulfill pharmaceutical needs, it is reasonable to assume the products will support military treatment facilities and beneficiaries within the agency's remit.

Generated 1/3/24, 11:59 AM